nodes	percent_of_prediction	percent_of_DWPC	metapath
Maraviroc—CCR5—Alzheimer's disease	0.656	1	CbGaD
Maraviroc—CYP3A4—Rivastigmine—Alzheimer's disease	0.0722	0.432	CbGbCtD
Maraviroc—CYP3A4—Donepezil—Alzheimer's disease	0.0577	0.345	CbGbCtD
Maraviroc—CYP3A4—Galantamine—Alzheimer's disease	0.0372	0.223	CbGbCtD
Maraviroc—CCR5—Peptide ligand-binding receptors—PYY—Alzheimer's disease	0.00105	0.0265	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—PTK2B—Alzheimer's disease	0.000936	0.0235	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—GAB2—Alzheimer's disease	0.00091	0.0229	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—PYY—Alzheimer's disease	0.000889	0.0223	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—GAL—Alzheimer's disease	0.00073	0.0183	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—PYY—Alzheimer's disease	0.000707	0.0177	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—HTR6—Alzheimer's disease	0.000689	0.0173	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—NOS2—Alzheimer's disease	0.000688	0.0173	CbGpPWpGaD
Maraviroc—CCR5—Chemokine receptors bind chemokines—CCL2—Alzheimer's disease	0.000656	0.0165	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—IL1A—Alzheimer's disease	0.000652	0.0164	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—GAL—Alzheimer's disease	0.000616	0.0155	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—HTR6—Alzheimer's disease	0.00059	0.0148	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—NPY—Alzheimer's disease	0.000574	0.0144	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Other—HTR2A—Alzheimer's disease	0.000569	0.0143	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—PYY—Alzheimer's disease	0.000538	0.0135	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—NPS—Alzheimer's disease	0.000525	0.0132	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—SST—Alzheimer's disease	0.000501	0.0126	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—GAL—Alzheimer's disease	0.00049	0.0123	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—APP—Alzheimer's disease	0.000488	0.0122	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—NPY—Alzheimer's disease	0.000484	0.0122	CbGpPWpGaD
Maraviroc—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—Alzheimer's disease	0.000484	0.0121	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—IL1B—Alzheimer's disease	0.000471	0.0118	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—CREB1—Alzheimer's disease	0.000458	0.0115	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—HTR6—Alzheimer's disease	0.000449	0.0113	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—SST—Alzheimer's disease	0.000422	0.0106	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—APP—Alzheimer's disease	0.000412	0.0103	CbGpPWpGaD
Maraviroc—CYP3A4—Tryptophan metabolism—DHCR24—Alzheimer's disease	0.000403	0.0101	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—NPY—Alzheimer's disease	0.000385	0.00966	CbGpPWpGaD
Maraviroc—CCR5—Disease—ITM2B—Alzheimer's disease	0.000385	0.00966	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—GAL—Alzheimer's disease	0.000373	0.00937	CbGpPWpGaD
Maraviroc—Abdominal distension—Donepezil—Alzheimer's disease	0.000358	0.00262	CcSEcCtD
Maraviroc—Influenza—Donepezil—Alzheimer's disease	0.000356	0.0026	CcSEcCtD
Maraviroc—Eosinophilia—Donepezil—Alzheimer's disease	0.000352	0.00257	CcSEcCtD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—NPS—Alzheimer's disease	0.000352	0.00884	CbGpPWpGaD
Maraviroc—Pancreatitis—Donepezil—Alzheimer's disease	0.000349	0.00255	CcSEcCtD
Maraviroc—CYP3A4—Constitutive Androstane Receptor Pathway—PPP2R4—Alzheimer's disease	0.000347	0.00872	CbGpPWpGaD
Maraviroc—Angina pectoris—Donepezil—Alzheimer's disease	0.000346	0.00253	CcSEcCtD
Maraviroc—Eye disorder—Galantamine—Alzheimer's disease	0.000343	0.00251	CcSEcCtD
Maraviroc—Bronchitis—Donepezil—Alzheimer's disease	0.000342	0.0025	CcSEcCtD
Maraviroc—Orthostatic hypotension—Memantine—Alzheimer's disease	0.000341	0.00249	CcSEcCtD
Maraviroc—Cardiac disorder—Galantamine—Alzheimer's disease	0.000341	0.00249	CcSEcCtD
Maraviroc—CCR5—TCR Signaling Pathway—IL1B—Alzheimer's disease	0.00034	0.00854	CbGpPWpGaD
Maraviroc—Aspartate aminotransferase increased—Memantine—Alzheimer's disease	0.000336	0.00246	CcSEcCtD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—SST—Alzheimer's disease	0.000336	0.00843	CbGpPWpGaD
Maraviroc—Nasopharyngitis—Memantine—Alzheimer's disease	0.000334	0.00244	CcSEcCtD
Maraviroc—Abdominal pain upper—Rivastigmine—Alzheimer's disease	0.000334	0.00244	CcSEcCtD
Maraviroc—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.000334	0.00244	CcSEcCtD
Maraviroc—Angiopathy—Galantamine—Alzheimer's disease	0.000333	0.00244	CcSEcCtD
Maraviroc—Breast disorder—Rivastigmine—Alzheimer's disease	0.00033	0.00241	CcSEcCtD
Maraviroc—Alanine aminotransferase increased—Memantine—Alzheimer's disease	0.00033	0.00241	CcSEcCtD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—APP—Alzheimer's disease	0.000327	0.00822	CbGpPWpGaD
Maraviroc—Nasopharyngitis—Rivastigmine—Alzheimer's disease	0.000327	0.00239	CcSEcCtD
Maraviroc—Influenza—Memantine—Alzheimer's disease	0.000323	0.00236	CcSEcCtD
Maraviroc—Mental disorder—Galantamine—Alzheimer's disease	0.000322	0.00235	CcSEcCtD
Maraviroc—Malnutrition—Galantamine—Alzheimer's disease	0.00032	0.00234	CcSEcCtD
Maraviroc—Pneumonia—Donepezil—Alzheimer's disease	0.000319	0.00233	CcSEcCtD
Maraviroc—Bronchospasm—Memantine—Alzheimer's disease	0.000318	0.00232	CcSEcCtD
Maraviroc—Infestation—Donepezil—Alzheimer's disease	0.000317	0.00232	CcSEcCtD
Maraviroc—Infestation NOS—Donepezil—Alzheimer's disease	0.000317	0.00232	CcSEcCtD
Maraviroc—Pancreatitis—Memantine—Alzheimer's disease	0.000317	0.00231	CcSEcCtD
Maraviroc—Depression—Donepezil—Alzheimer's disease	0.000316	0.00231	CcSEcCtD
Maraviroc—Flatulence—Galantamine—Alzheimer's disease	0.000315	0.0023	CcSEcCtD
Maraviroc—Angina pectoris—Memantine—Alzheimer's disease	0.000315	0.0023	CcSEcCtD
Maraviroc—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.000313	0.00229	CcSEcCtD
Maraviroc—CCR5—TCR Signaling Pathway—MAPK8—Alzheimer's disease	0.000312	0.00783	CbGpPWpGaD
Maraviroc—Renal failure—Donepezil—Alzheimer's disease	0.000312	0.00228	CcSEcCtD
Maraviroc—Myocardial infarction—Donepezil—Alzheimer's disease	0.000311	0.00227	CcSEcCtD
Maraviroc—Bronchospasm—Rivastigmine—Alzheimer's disease	0.000311	0.00227	CcSEcCtD
Maraviroc—Bronchitis—Memantine—Alzheimer's disease	0.000311	0.00227	CcSEcCtD
Maraviroc—Pancreatitis—Rivastigmine—Alzheimer's disease	0.00031	0.00226	CcSEcCtD
Maraviroc—Jaundice—Donepezil—Alzheimer's disease	0.000309	0.00226	CcSEcCtD
Maraviroc—Conjunctivitis—Donepezil—Alzheimer's disease	0.000308	0.00225	CcSEcCtD
Maraviroc—Angina pectoris—Rivastigmine—Alzheimer's disease	0.000308	0.00225	CcSEcCtD
Maraviroc—CCR5—Disease—GAPDHS—Alzheimer's disease	0.000307	0.00772	CbGpPWpGaD
Maraviroc—Pancytopenia—Memantine—Alzheimer's disease	0.000307	0.00224	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—PYY—Alzheimer's disease	0.000304	0.00764	CbGpPWpGaD
Maraviroc—Bronchitis—Rivastigmine—Alzheimer's disease	0.000304	0.00222	CcSEcCtD
Maraviroc—Neutropenia—Memantine—Alzheimer's disease	0.000302	0.00221	CcSEcCtD
Maraviroc—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.0003	0.00219	CcSEcCtD
Maraviroc—Tremor—Galantamine—Alzheimer's disease	0.0003	0.00219	CcSEcCtD
Maraviroc—Anaemia—Galantamine—Alzheimer's disease	0.000296	0.00216	CcSEcCtD
Maraviroc—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.000294	0.00215	CcSEcCtD
Maraviroc—CCR5—GPCR ligand binding—NPY—Alzheimer's disease	0.000293	0.00736	CbGpPWpGaD
Maraviroc—CYP3A4—Irinotecan Pathway—BCHE—Alzheimer's disease	0.000293	0.00735	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—IAPP—Alzheimer's disease	0.000291	0.00731	CbGpPWpGaD
Maraviroc—Pneumonia—Memantine—Alzheimer's disease	0.00029	0.00212	CcSEcCtD
Maraviroc—Infestation—Memantine—Alzheimer's disease	0.000288	0.0021	CcSEcCtD
Maraviroc—Infestation NOS—Memantine—Alzheimer's disease	0.000288	0.0021	CcSEcCtD
Maraviroc—Depression—Memantine—Alzheimer's disease	0.000287	0.0021	CcSEcCtD
Maraviroc—Syncope—Galantamine—Alzheimer's disease	0.000287	0.0021	CcSEcCtD
Maraviroc—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.000285	0.00209	CcSEcCtD
Maraviroc—Rhinitis—Donepezil—Alzheimer's disease	0.000285	0.00209	CcSEcCtD
Maraviroc—Acute coronary syndrome—Memantine—Alzheimer's disease	0.000284	0.00207	CcSEcCtD
Maraviroc—Pneumonia—Rivastigmine—Alzheimer's disease	0.000283	0.00207	CcSEcCtD
Maraviroc—Hallucination—Donepezil—Alzheimer's disease	0.000283	0.00207	CcSEcCtD
Maraviroc—Renal failure—Memantine—Alzheimer's disease	0.000283	0.00207	CcSEcCtD
Maraviroc—CCR5—GPCR ligand binding—CRH—Alzheimer's disease	0.000283	0.0071	CbGpPWpGaD
Maraviroc—Pharyngitis—Donepezil—Alzheimer's disease	0.000283	0.00207	CcSEcCtD
Maraviroc—Myocardial infarction—Memantine—Alzheimer's disease	0.000282	0.00206	CcSEcCtD
Maraviroc—Neuropathy peripheral—Memantine—Alzheimer's disease	0.000282	0.00206	CcSEcCtD
Maraviroc—Infestation—Rivastigmine—Alzheimer's disease	0.000282	0.00206	CcSEcCtD
Maraviroc—Infestation NOS—Rivastigmine—Alzheimer's disease	0.000282	0.00206	CcSEcCtD
Maraviroc—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000281	0.00206	CcSEcCtD
Maraviroc—Loss of consciousness—Galantamine—Alzheimer's disease	0.000281	0.00205	CcSEcCtD
Maraviroc—Depression—Rivastigmine—Alzheimer's disease	0.000281	0.00205	CcSEcCtD
Maraviroc—Conjunctivitis—Memantine—Alzheimer's disease	0.00028	0.00205	CcSEcCtD
Maraviroc—CYP3A4—Tryptophan metabolism—HSD17B10—Alzheimer's disease	0.000279	0.00702	CbGpPWpGaD
Maraviroc—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.000279	0.00204	CcSEcCtD
Maraviroc—Urethral disorder—Donepezil—Alzheimer's disease	0.000279	0.00204	CcSEcCtD
Maraviroc—Cough—Galantamine—Alzheimer's disease	0.000279	0.00204	CcSEcCtD
Maraviroc—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000278	0.00203	CcSEcCtD
Maraviroc—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Alzheimer's disease	0.000278	0.00697	CbGpPWpGaD
Maraviroc—Convulsion—Galantamine—Alzheimer's disease	0.000277	0.00203	CcSEcCtD
Maraviroc—Renal failure—Rivastigmine—Alzheimer's disease	0.000277	0.00202	CcSEcCtD
Maraviroc—CCR5—Peptide ligand-binding receptors—F2—Alzheimer's disease	0.000277	0.00695	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—PYY—Alzheimer's disease	0.000276	0.00694	CbGpPWpGaD
Maraviroc—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000276	0.00202	CcSEcCtD
Maraviroc—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000276	0.00202	CcSEcCtD
Maraviroc—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000274	0.002	CcSEcCtD
Maraviroc—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000272	0.00199	CcSEcCtD
Maraviroc—Myalgia—Galantamine—Alzheimer's disease	0.000272	0.00199	CcSEcCtD
Maraviroc—Anxiety—Galantamine—Alzheimer's disease	0.000271	0.00198	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00027	0.00198	CcSEcCtD
Maraviroc—Sinusitis—Memantine—Alzheimer's disease	0.00027	0.00197	CcSEcCtD
Maraviroc—Discomfort—Galantamine—Alzheimer's disease	0.000269	0.00197	CcSEcCtD
Maraviroc—Agranulocytosis—Memantine—Alzheimer's disease	0.000269	0.00196	CcSEcCtD
Maraviroc—CCR5—GPCR ligand binding—NPS—Alzheimer's disease	0.000268	0.00673	CbGpPWpGaD
Maraviroc—CCR5—Disease—TTR—Alzheimer's disease	0.000267	0.00669	CbGpPWpGaD
Maraviroc—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000266	0.00195	CcSEcCtD
Maraviroc—CCR5—TCR Signaling Pathway—TGFB1—Alzheimer's disease	0.000264	0.00664	CbGpPWpGaD
Maraviroc—Sinusitis—Rivastigmine—Alzheimer's disease	0.000264	0.00193	CcSEcCtD
Maraviroc—Rhinitis—Memantine—Alzheimer's disease	0.000259	0.00189	CcSEcCtD
Maraviroc—Hallucination—Memantine—Alzheimer's disease	0.000257	0.00188	CcSEcCtD
Maraviroc—Shock—Galantamine—Alzheimer's disease	0.000257	0.00188	CcSEcCtD
Maraviroc—Pharyngitis—Memantine—Alzheimer's disease	0.000257	0.00188	CcSEcCtD
Maraviroc—Nervous system disorder—Galantamine—Alzheimer's disease	0.000256	0.00187	CcSEcCtD
Maraviroc—CCR5—GPCR ligand binding—SST—Alzheimer's disease	0.000256	0.00642	CbGpPWpGaD
Maraviroc—Urinary tract disorder—Memantine—Alzheimer's disease	0.000255	0.00187	CcSEcCtD
Maraviroc—Connective tissue disorder—Memantine—Alzheimer's disease	0.000254	0.00186	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—HTR6—Alzheimer's disease	0.000254	0.00637	CbGpPWpGaD
Maraviroc—Rhinitis—Rivastigmine—Alzheimer's disease	0.000254	0.00185	CcSEcCtD
Maraviroc—Skin disorder—Galantamine—Alzheimer's disease	0.000254	0.00185	CcSEcCtD
Maraviroc—Urethral disorder—Memantine—Alzheimer's disease	0.000253	0.00185	CcSEcCtD
Maraviroc—Hallucination—Rivastigmine—Alzheimer's disease	0.000252	0.00184	CcSEcCtD
Maraviroc—Alopecia—Donepezil—Alzheimer's disease	0.000252	0.00184	CcSEcCtD
Maraviroc—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000251	0.00183	CcSEcCtD
Maraviroc—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.00025	0.00183	CcSEcCtD
Maraviroc—Mental disorder—Donepezil—Alzheimer's disease	0.000249	0.00182	CcSEcCtD
Maraviroc—CCR5—GPCR ligand binding—APP—Alzheimer's disease	0.000249	0.00626	CbGpPWpGaD
Maraviroc—Anorexia—Galantamine—Alzheimer's disease	0.000249	0.00182	CcSEcCtD
Maraviroc—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000249	0.00182	CcSEcCtD
Maraviroc—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000248	0.00181	CcSEcCtD
Maraviroc—Erythema—Donepezil—Alzheimer's disease	0.000248	0.00181	CcSEcCtD
Maraviroc—Malnutrition—Donepezil—Alzheimer's disease	0.000248	0.00181	CcSEcCtD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	0.000247	0.00621	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—CCL2—Alzheimer's disease	0.000247	0.00619	CbGpPWpGaD
Maraviroc—Erythema multiforme—Memantine—Alzheimer's disease	0.000244	0.00179	CcSEcCtD
Maraviroc—Flatulence—Donepezil—Alzheimer's disease	0.000244	0.00179	CcSEcCtD
Maraviroc—Eye disorder—Memantine—Alzheimer's disease	0.000242	0.00177	CcSEcCtD
Maraviroc—Cardiac disorder—Memantine—Alzheimer's disease	0.00024	0.00175	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—CDK5—Alzheimer's disease	0.00024	0.00601	CbGpPWpGaD
Maraviroc—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000239	0.00175	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000238	0.00174	CcSEcCtD
Maraviroc—Eye disorder—Rivastigmine—Alzheimer's disease	0.000236	0.00173	CcSEcCtD
Maraviroc—Insomnia—Galantamine—Alzheimer's disease	0.000236	0.00173	CcSEcCtD
Maraviroc—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000235	0.00172	CcSEcCtD
Maraviroc—Angiopathy—Memantine—Alzheimer's disease	0.000235	0.00171	CcSEcCtD
Maraviroc—Paraesthesia—Galantamine—Alzheimer's disease	0.000234	0.00171	CcSEcCtD
Maraviroc—Mediastinal disorder—Memantine—Alzheimer's disease	0.000233	0.0017	CcSEcCtD
Maraviroc—CYP3A4—Xenobiotics—CYP2D6—Alzheimer's disease	0.000232	0.00583	CbGpPWpGaD
Maraviroc—Tremor—Donepezil—Alzheimer's disease	0.000232	0.0017	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—HTR6—Alzheimer's disease	0.000231	0.00579	CbGpPWpGaD
Maraviroc—Angiopathy—Rivastigmine—Alzheimer's disease	0.000229	0.00168	CcSEcCtD
Maraviroc—Anaemia—Donepezil—Alzheimer's disease	0.000229	0.00167	CcSEcCtD
Maraviroc—Alopecia—Memantine—Alzheimer's disease	0.000228	0.00167	CcSEcCtD
Maraviroc—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000228	0.00167	CcSEcCtD
Maraviroc—Decreased appetite—Galantamine—Alzheimer's disease	0.000227	0.00166	CcSEcCtD
Maraviroc—Mental disorder—Memantine—Alzheimer's disease	0.000226	0.00166	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000225	0.00165	CcSEcCtD
Maraviroc—Malnutrition—Memantine—Alzheimer's disease	0.000225	0.00164	CcSEcCtD
Maraviroc—Fatigue—Galantamine—Alzheimer's disease	0.000225	0.00164	CcSEcCtD
Maraviroc—Alopecia—Rivastigmine—Alzheimer's disease	0.000223	0.00163	CcSEcCtD
Maraviroc—CYP3A4—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	0.000223	0.00561	CbGpPWpGaD
Maraviroc—Constipation—Galantamine—Alzheimer's disease	0.000223	0.00163	CcSEcCtD
Maraviroc—Syncope—Donepezil—Alzheimer's disease	0.000222	0.00162	CcSEcCtD
Maraviroc—Flatulence—Memantine—Alzheimer's disease	0.000222	0.00162	CcSEcCtD
Maraviroc—Mental disorder—Rivastigmine—Alzheimer's disease	0.000222	0.00162	CcSEcCtD
Maraviroc—Erythema—Rivastigmine—Alzheimer's disease	0.00022	0.00161	CcSEcCtD
Maraviroc—Malnutrition—Rivastigmine—Alzheimer's disease	0.00022	0.00161	CcSEcCtD
Maraviroc—Loss of consciousness—Donepezil—Alzheimer's disease	0.000218	0.00159	CcSEcCtD
Maraviroc—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.000218	0.00546	CbGpPWpGaD
Maraviroc—Flatulence—Rivastigmine—Alzheimer's disease	0.000217	0.00159	CcSEcCtD
Maraviroc—Cough—Donepezil—Alzheimer's disease	0.000216	0.00158	CcSEcCtD
Maraviroc—Convulsion—Donepezil—Alzheimer's disease	0.000215	0.00157	CcSEcCtD
Maraviroc—CYP3A4—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.000215	0.00539	CbGpPWpGaD
Maraviroc—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000213	0.00156	CcSEcCtD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	0.000212	0.00532	CbGpPWpGaD
Maraviroc—Myalgia—Donepezil—Alzheimer's disease	0.000211	0.00154	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—GAL—Alzheimer's disease	0.000211	0.00529	CbGpPWpGaD
Maraviroc—Tremor—Memantine—Alzheimer's disease	0.000211	0.00154	CcSEcCtD
Maraviroc—Anxiety—Donepezil—Alzheimer's disease	0.00021	0.00154	CcSEcCtD
Maraviroc—Discomfort—Donepezil—Alzheimer's disease	0.000208	0.00152	CcSEcCtD
Maraviroc—Anaemia—Memantine—Alzheimer's disease	0.000208	0.00152	CcSEcCtD
Maraviroc—Body temperature increased—Galantamine—Alzheimer's disease	0.000206	0.00151	CcSEcCtD
Maraviroc—Abdominal pain—Galantamine—Alzheimer's disease	0.000206	0.00151	CcSEcCtD
Maraviroc—Tremor—Rivastigmine—Alzheimer's disease	0.000206	0.00151	CcSEcCtD
Maraviroc—Anaemia—Rivastigmine—Alzheimer's disease	0.000203	0.00149	CcSEcCtD
Maraviroc—Oedema—Donepezil—Alzheimer's disease	0.000202	0.00148	CcSEcCtD
Maraviroc—Syncope—Memantine—Alzheimer's disease	0.000202	0.00148	CcSEcCtD
Maraviroc—Leukopenia—Memantine—Alzheimer's disease	0.000201	0.00147	CcSEcCtD
Maraviroc—Infection—Donepezil—Alzheimer's disease	0.000201	0.00147	CcSEcCtD
Maraviroc—CCR5—TCR Signaling Pathway—IL6—Alzheimer's disease	0.000199	0.005	CbGpPWpGaD
Maraviroc—Shock—Donepezil—Alzheimer's disease	0.000199	0.00145	CcSEcCtD
Maraviroc—Nervous system disorder—Donepezil—Alzheimer's disease	0.000198	0.00145	CcSEcCtD
Maraviroc—CCR5—Disease—SNCA—Alzheimer's disease	0.000198	0.00497	CbGpPWpGaD
Maraviroc—Loss of consciousness—Memantine—Alzheimer's disease	0.000198	0.00145	CcSEcCtD
Maraviroc—Syncope—Rivastigmine—Alzheimer's disease	0.000197	0.00144	CcSEcCtD
Maraviroc—Cough—Memantine—Alzheimer's disease	0.000196	0.00144	CcSEcCtD
Maraviroc—Convulsion—Memantine—Alzheimer's disease	0.000195	0.00143	CcSEcCtD
Maraviroc—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000193	0.00141	CcSEcCtD
Maraviroc—Anorexia—Donepezil—Alzheimer's disease	0.000193	0.00141	CcSEcCtD
Maraviroc—Hypersensitivity—Galantamine—Alzheimer's disease	0.000192	0.00141	CcSEcCtD
Maraviroc—Cough—Rivastigmine—Alzheimer's disease	0.000192	0.0014	CcSEcCtD
Maraviroc—Myalgia—Memantine—Alzheimer's disease	0.000192	0.0014	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—GAL—Alzheimer's disease	0.000191	0.00481	CbGpPWpGaD
Maraviroc—Anxiety—Memantine—Alzheimer's disease	0.000191	0.0014	CcSEcCtD
Maraviroc—Convulsion—Rivastigmine—Alzheimer's disease	0.000191	0.00139	CcSEcCtD
Maraviroc—Discomfort—Memantine—Alzheimer's disease	0.000189	0.00138	CcSEcCtD
Maraviroc—Myalgia—Rivastigmine—Alzheimer's disease	0.000187	0.00137	CcSEcCtD
Maraviroc—Asthenia—Galantamine—Alzheimer's disease	0.000187	0.00137	CcSEcCtD
Maraviroc—Anxiety—Rivastigmine—Alzheimer's disease	0.000187	0.00137	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—TTR—Alzheimer's disease	0.000187	0.00469	CbGpPWpGaD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000186	0.00136	CcSEcCtD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	0.000186	0.00466	CbGpPWpGaD
Maraviroc—Discomfort—Rivastigmine—Alzheimer's disease	0.000185	0.00135	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000184	0.00135	CcSEcCtD
Maraviroc—CCR5—TCR Signaling Pathway—AKT1—Alzheimer's disease	0.000184	0.00461	CbGpPWpGaD
Maraviroc—Oedema—Memantine—Alzheimer's disease	0.000184	0.00134	CcSEcCtD
Maraviroc—Insomnia—Donepezil—Alzheimer's disease	0.000183	0.00134	CcSEcCtD
Maraviroc—Infection—Memantine—Alzheimer's disease	0.000182	0.00133	CcSEcCtD
Maraviroc—Paraesthesia—Donepezil—Alzheimer's disease	0.000182	0.00133	CcSEcCtD
Maraviroc—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—Alzheimer's disease	0.000181	0.00454	CbGpPWpGaD
Maraviroc—Shock—Memantine—Alzheimer's disease	0.000181	0.00132	CcSEcCtD
Maraviroc—Nervous system disorder—Memantine—Alzheimer's disease	0.00018	0.00132	CcSEcCtD
Maraviroc—Oedema—Rivastigmine—Alzheimer's disease	0.00018	0.00131	CcSEcCtD
Maraviroc—Diarrhoea—Galantamine—Alzheimer's disease	0.000179	0.00131	CcSEcCtD
Maraviroc—Infection—Rivastigmine—Alzheimer's disease	0.000178	0.0013	CcSEcCtD
Maraviroc—Skin disorder—Memantine—Alzheimer's disease	0.000178	0.0013	CcSEcCtD
Maraviroc—Shock—Rivastigmine—Alzheimer's disease	0.000177	0.00129	CcSEcCtD
Maraviroc—CCR5—Disease—PSENEN—Alzheimer's disease	0.000177	0.00443	CbGpPWpGaD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.000176	0.00443	CbGpPWpGaD
Maraviroc—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000176	0.00129	CcSEcCtD
Maraviroc—Decreased appetite—Donepezil—Alzheimer's disease	0.000176	0.00129	CcSEcCtD
Maraviroc—Anorexia—Memantine—Alzheimer's disease	0.000175	0.00128	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000175	0.00128	CcSEcCtD
Maraviroc—Skin disorder—Rivastigmine—Alzheimer's disease	0.000175	0.00128	CcSEcCtD
Maraviroc—Fatigue—Donepezil—Alzheimer's disease	0.000174	0.00127	CcSEcCtD
Maraviroc—CCR5—Disease—APH1A—Alzheimer's disease	0.000174	0.00437	CbGpPWpGaD
Maraviroc—Pain—Donepezil—Alzheimer's disease	0.000173	0.00126	CcSEcCtD
Maraviroc—Constipation—Donepezil—Alzheimer's disease	0.000173	0.00126	CcSEcCtD
Maraviroc—Dizziness—Galantamine—Alzheimer's disease	0.000173	0.00126	CcSEcCtD
Maraviroc—Anorexia—Rivastigmine—Alzheimer's disease	0.000171	0.00125	CcSEcCtD
Maraviroc—CCR5—Disease—NCSTN—Alzheimer's disease	0.00017	0.00426	CbGpPWpGaD
Maraviroc—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000167	0.00122	CcSEcCtD
Maraviroc—Insomnia—Memantine—Alzheimer's disease	0.000166	0.00121	CcSEcCtD
Maraviroc—Vomiting—Galantamine—Alzheimer's disease	0.000166	0.00121	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—NPY—Alzheimer's disease	0.000166	0.00416	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	0.000165	0.00415	CbGpPWpGaD
Maraviroc—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000165	0.00121	CcSEcCtD
Maraviroc—CCR5—Disease—LRP1—Alzheimer's disease	0.000165	0.00415	CbGpPWpGaD
Maraviroc—Paraesthesia—Memantine—Alzheimer's disease	0.000165	0.00121	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—IAPP—Alzheimer's disease	0.000165	0.00413	CbGpPWpGaD
Maraviroc—Rash—Galantamine—Alzheimer's disease	0.000165	0.0012	CcSEcCtD
Maraviroc—Dermatitis—Galantamine—Alzheimer's disease	0.000164	0.0012	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000164	0.0012	CcSEcCtD
Maraviroc—Headache—Galantamine—Alzheimer's disease	0.000164	0.0012	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—PYY—Alzheimer's disease	0.000163	0.0041	CbGpPWpGaD
Maraviroc—Insomnia—Rivastigmine—Alzheimer's disease	0.000163	0.00119	CcSEcCtD
Maraviroc—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000161	0.00118	CcSEcCtD
Maraviroc—CCR5—GPCR ligand binding—HTR2A—Alzheimer's disease	0.000161	0.00405	CbGpPWpGaD
Maraviroc—CYP3A4—Tryptophan metabolism—MAOB—Alzheimer's disease	0.000161	0.00403	CbGpPWpGaD
Maraviroc—Body temperature increased—Donepezil—Alzheimer's disease	0.00016	0.00117	CcSEcCtD
Maraviroc—Abdominal pain—Donepezil—Alzheimer's disease	0.00016	0.00117	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—CRH—Alzheimer's disease	0.00016	0.00401	CbGpPWpGaD
Maraviroc—CCR5—Disease—TPI1—Alzheimer's disease	0.00016	0.00401	CbGpPWpGaD
Maraviroc—Decreased appetite—Memantine—Alzheimer's disease	0.00016	0.00117	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000159	0.00116	CcSEcCtD
Maraviroc—Fatigue—Memantine—Alzheimer's disease	0.000158	0.00116	CcSEcCtD
Maraviroc—Pain—Memantine—Alzheimer's disease	0.000157	0.00115	CcSEcCtD
Maraviroc—Constipation—Memantine—Alzheimer's disease	0.000157	0.00115	CcSEcCtD
Maraviroc—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000156	0.00114	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000155	0.00113	CcSEcCtD
Maraviroc—Nausea—Galantamine—Alzheimer's disease	0.000155	0.00113	CcSEcCtD
Maraviroc—Fatigue—Rivastigmine—Alzheimer's disease	0.000155	0.00113	CcSEcCtD
Maraviroc—Constipation—Rivastigmine—Alzheimer's disease	0.000154	0.00112	CcSEcCtD
Maraviroc—Pain—Rivastigmine—Alzheimer's disease	0.000154	0.00112	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—NPS—Alzheimer's disease	0.000151	0.0038	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—NPY—Alzheimer's disease	0.00015	0.00378	CbGpPWpGaD
Maraviroc—Gastrointestinal pain—Memantine—Alzheimer's disease	0.00015	0.0011	CcSEcCtD
Maraviroc—CCR5—Disease—EIF2AK2—Alzheimer's disease	0.00015	0.00377	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—IAPP—Alzheimer's disease	0.000149	0.00375	CbGpPWpGaD
Maraviroc—Hypersensitivity—Donepezil—Alzheimer's disease	0.000149	0.00109	CcSEcCtD
Maraviroc—CCR5—Disease—GAPDH—Alzheimer's disease	0.000147	0.0037	CbGpPWpGaD
Maraviroc—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000147	0.00107	CcSEcCtD
Maraviroc—Body temperature increased—Memantine—Alzheimer's disease	0.000145	0.00106	CcSEcCtD
Maraviroc—Abdominal pain—Memantine—Alzheimer's disease	0.000145	0.00106	CcSEcCtD
Maraviroc—Asthenia—Donepezil—Alzheimer's disease	0.000145	0.00106	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—CRH—Alzheimer's disease	0.000145	0.00364	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—SST—Alzheimer's disease	0.000145	0.00363	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—GAB2—Alzheimer's disease	0.000145	0.00363	CbGpPWpGaD
Maraviroc—Pruritus—Donepezil—Alzheimer's disease	0.000143	0.00105	CcSEcCtD
Maraviroc—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000142	0.00104	CcSEcCtD
Maraviroc—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000142	0.00104	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—CDK5—Alzheimer's disease	0.000141	0.00355	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—F2—Alzheimer's disease	0.000141	0.00355	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—APP—Alzheimer's disease	0.000141	0.00354	CbGpPWpGaD
Maraviroc—Diarrhoea—Donepezil—Alzheimer's disease	0.000138	0.00101	CcSEcCtD
Maraviroc—CCR5—Disease—PSEN2—Alzheimer's disease	0.000138	0.00346	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—NPS—Alzheimer's disease	0.000138	0.00345	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000137	0.00344	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—HTR6—Alzheimer's disease	0.000136	0.00342	CbGpPWpGaD
Maraviroc—Hypersensitivity—Memantine—Alzheimer's disease	0.000135	0.000989	CcSEcCtD
Maraviroc—CCR5—Disease—CST3—Alzheimer's disease	0.000135	0.00338	CbGpPWpGaD
Maraviroc—Dizziness—Donepezil—Alzheimer's disease	0.000134	0.000978	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000133	0.00334	CbGpPWpGaD
Maraviroc—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000132	0.000968	CcSEcCtD
Maraviroc—Asthenia—Memantine—Alzheimer's disease	0.000132	0.000963	CcSEcCtD
Maraviroc—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	0.000132	0.00331	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—GAB2—Alzheimer's disease	0.000131	0.00329	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—SST—Alzheimer's disease	0.000131	0.00329	CbGpPWpGaD
Maraviroc—Pruritus—Memantine—Alzheimer's disease	0.00013	0.00095	CcSEcCtD
Maraviroc—Asthenia—Rivastigmine—Alzheimer's disease	0.000129	0.000942	CcSEcCtD
Maraviroc—Vomiting—Donepezil—Alzheimer's disease	0.000129	0.00094	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—APP—Alzheimer's disease	0.000128	0.00321	CbGpPWpGaD
Maraviroc—Rash—Donepezil—Alzheimer's disease	0.000128	0.000932	CcSEcCtD
Maraviroc—Dermatitis—Donepezil—Alzheimer's disease	0.000127	0.000931	CcSEcCtD
Maraviroc—Pruritus—Rivastigmine—Alzheimer's disease	0.000127	0.000929	CcSEcCtD
Maraviroc—Headache—Donepezil—Alzheimer's disease	0.000127	0.000926	CcSEcCtD
Maraviroc—CCR5—Disease—IAPP—Alzheimer's disease	0.000126	0.00317	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CCL2—Alzheimer's disease	0.000126	0.00316	CbGpPWpGaD
Maraviroc—Diarrhoea—Memantine—Alzheimer's disease	0.000126	0.000918	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—PSENEN—Alzheimer's disease	0.000124	0.0031	CbGpPWpGaD
Maraviroc—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000123	0.000899	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—APH1A—Alzheimer's disease	0.000122	0.00306	CbGpPWpGaD
Maraviroc—Dizziness—Memantine—Alzheimer's disease	0.000121	0.000888	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000121	0.00303	CbGpPWpGaD
Maraviroc—Nausea—Donepezil—Alzheimer's disease	0.00012	0.000878	CcSEcCtD
Maraviroc—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	0.000119	0.00299	CbGpPWpGaD
Maraviroc—Dizziness—Rivastigmine—Alzheimer's disease	0.000119	0.000868	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—NCSTN—Alzheimer's disease	0.000119	0.00298	CbGpPWpGaD
Maraviroc—Vomiting—Memantine—Alzheimer's disease	0.000117	0.000853	CcSEcCtD
Maraviroc—CCR5—Disease—ENO1—Alzheimer's disease	0.000116	0.00291	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—LRP1—Alzheimer's disease	0.000116	0.00291	CbGpPWpGaD
Maraviroc—Rash—Memantine—Alzheimer's disease	0.000116	0.000846	CcSEcCtD
Maraviroc—Dermatitis—Memantine—Alzheimer's disease	0.000116	0.000846	CcSEcCtD
Maraviroc—CCR5—Disease—PPP3CA—Alzheimer's disease	0.000115	0.0029	CbGpPWpGaD
Maraviroc—Headache—Memantine—Alzheimer's disease	0.000115	0.000841	CcSEcCtD
Maraviroc—Vomiting—Rivastigmine—Alzheimer's disease	0.000114	0.000835	CcSEcCtD
Maraviroc—Rash—Rivastigmine—Alzheimer's disease	0.000113	0.000828	CcSEcCtD
Maraviroc—Dermatitis—Rivastigmine—Alzheimer's disease	0.000113	0.000827	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—GFAP—Alzheimer's disease	0.000113	0.00284	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—GAL—Alzheimer's disease	0.000113	0.00284	CbGpPWpGaD
Maraviroc—Headache—Rivastigmine—Alzheimer's disease	0.000113	0.000823	CcSEcCtD
Maraviroc—CCR5—Disease—GAB2—Alzheimer's disease	0.000111	0.00278	CbGpPWpGaD
Maraviroc—CCR5—Disease—GSK3A—Alzheimer's disease	0.00011	0.00276	CbGpPWpGaD
Maraviroc—Nausea—Memantine—Alzheimer's disease	0.000109	0.000797	CcSEcCtD
Maraviroc—CCR5—Disease—APP—Alzheimer's disease	0.000108	0.00271	CbGpPWpGaD
Maraviroc—Nausea—Rivastigmine—Alzheimer's disease	0.000107	0.00078	CcSEcCtD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000105	0.00264	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—A2M—Alzheimer's disease	9.97e-05	0.0025	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—PRKCG—Alzheimer's disease	9.83e-05	0.00247	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PSEN2—Alzheimer's disease	9.65e-05	0.00242	CbGpPWpGaD
Maraviroc—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	9.65e-05	0.00242	CbGpPWpGaD
Maraviroc—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	9.52e-05	0.00239	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—CYP46A1—Alzheimer's disease	9.37e-05	0.00235	CbGpPWpGaD
Maraviroc—CCR5—Disease—ADAM10—Alzheimer's disease	9.28e-05	0.00233	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—CYP46A1—Alzheimer's disease	9.24e-05	0.00232	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—HTR2A—Alzheimer's disease	9.11e-05	0.00229	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—PRKCG—Alzheimer's disease	8.92e-05	0.00224	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NPY—Alzheimer's disease	8.89e-05	0.00223	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IAPP—Alzheimer's disease	8.83e-05	0.00222	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CRH—Alzheimer's disease	8.57e-05	0.00215	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—HTR2A—Alzheimer's disease	8.28e-05	0.00208	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NPS—Alzheimer's disease	8.13e-05	0.00204	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PPP3CA—Alzheimer's disease	8.09e-05	0.00203	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—F2—Alzheimer's disease	7.99e-05	0.00201	CbGpPWpGaD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	7.97e-05	0.002	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PTK2B—Alzheimer's disease	7.97e-05	0.002	CbGpPWpGaD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	7.82e-05	0.00196	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—SST—Alzheimer's disease	7.75e-05	0.00195	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—GAB2—Alzheimer's disease	7.75e-05	0.00195	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NTRK2—Alzheimer's disease	7.75e-05	0.00195	CbGpPWpGaD
Maraviroc—CCR5—Disease—LPL—Alzheimer's disease	7.74e-05	0.00194	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CALM1—Alzheimer's disease	7.72e-05	0.00194	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—GSK3A—Alzheimer's disease	7.68e-05	0.00193	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—APP—Alzheimer's disease	7.55e-05	0.0019	CbGpPWpGaD
Maraviroc—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	7.55e-05	0.0019	CbGpPWpGaD
Maraviroc—CCR5—Disease—PRKCG—Alzheimer's disease	7.53e-05	0.00189	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—F2—Alzheimer's disease	7.26e-05	0.00182	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PLCB1—Alzheimer's disease	7.13e-05	0.00179	CbGpPWpGaD
Maraviroc—CCR5—Disease—MTHFR—Alzheimer's disease	6.97e-05	0.00175	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NGFR—Alzheimer's disease	6.65e-05	0.00167	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CREB1—Alzheimer's disease	6.61e-05	0.00166	CbGpPWpGaD
Maraviroc—CCR5—Disease—CALM1—Alzheimer's disease	6.51e-05	0.00164	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—ADAM10—Alzheimer's disease	6.5e-05	0.00163	CbGpPWpGaD
Maraviroc—CCR5—Disease—APOE—Alzheimer's disease	6.49e-05	0.00163	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CCL2—Alzheimer's disease	6.47e-05	0.00162	CbGpPWpGaD
Maraviroc—CCR5—Disease—CAV1—Alzheimer's disease	6.43e-05	0.00161	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—S100B—Alzheimer's disease	6.14e-05	0.00154	CbGpPWpGaD
Maraviroc—CCR5—Disease—NOS2—Alzheimer's disease	6.05e-05	0.00152	CbGpPWpGaD
Maraviroc—CCR5—Disease—NOTCH1—Alzheimer's disease	5.99e-05	0.0015	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IGF2—Alzheimer's disease	5.85e-05	0.00147	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IGF1R—Alzheimer's disease	5.66e-05	0.00142	CbGpPWpGaD
Maraviroc—CCR5—Disease—GSK3B—Alzheimer's disease	5.62e-05	0.00141	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	5.59e-05	0.0014	CbGpPWpGaD
Maraviroc—CCR5—Disease—CREB1—Alzheimer's disease	5.58e-05	0.0014	CbGpPWpGaD
Maraviroc—CCR5—Disease—INS—Alzheimer's disease	5.54e-05	0.00139	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—LPL—Alzheimer's disease	5.42e-05	0.00136	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—MEF2C—Alzheimer's disease	5.37e-05	0.00135	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PRKCG—Alzheimer's disease	5.27e-05	0.00132	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NGF—Alzheimer's disease	5.14e-05	0.00129	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—HTR2A—Alzheimer's disease	4.89e-05	0.00123	CbGpPWpGaD
Maraviroc—CCR5—Disease—NOS3—Alzheimer's disease	4.86e-05	0.00122	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CALM1—Alzheimer's disease	4.56e-05	0.00115	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—LEP—Alzheimer's disease	4.54e-05	0.00114	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—APOE—Alzheimer's disease	4.54e-05	0.00114	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CAV1—Alzheimer's disease	4.5e-05	0.00113	CbGpPWpGaD
Maraviroc—CCR5—Disease—PTGS2—Alzheimer's disease	4.45e-05	0.00112	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—ESR1—Alzheimer's disease	4.34e-05	0.00109	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—F2—Alzheimer's disease	4.29e-05	0.00108	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	4.24e-05	0.00106	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NOTCH1—Alzheimer's disease	4.19e-05	0.00105	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	4.15e-05	0.00104	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	4.1e-05	0.00103	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—GSK3B—Alzheimer's disease	3.94e-05	0.000988	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CREB1—Alzheimer's disease	3.9e-05	0.00098	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—INS—Alzheimer's disease	3.88e-05	0.000975	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CCL2—Alzheimer's disease	3.82e-05	0.000959	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IGF1—Alzheimer's disease	3.76e-05	0.000943	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NOS3—Alzheimer's disease	3.4e-05	0.000855	CbGpPWpGaD
Maraviroc—CCR5—Disease—TGFB1—Alzheimer's disease	3.22e-05	0.000807	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—AKT1—Alzheimer's disease	2.92e-05	0.000733	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CASP3—Alzheimer's disease	2.89e-05	0.000726	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—IL6—Alzheimer's disease	2.87e-05	0.000721	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—MAPK8—Alzheimer's disease	2.66e-05	0.000667	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—AKT1—Alzheimer's disease	2.65e-05	0.000665	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—VEGFA—Alzheimer's disease	2.45e-05	0.000616	CbGpPWpGaD
Maraviroc—CCR5—Disease—IL6—Alzheimer's disease	2.42e-05	0.000608	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	2.4e-05	0.000603	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TGFB1—Alzheimer's disease	2.25e-05	0.000565	CbGpPWpGaD
Maraviroc—CCR5—Disease—AKT1—Alzheimer's disease	2.24e-05	0.000561	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CA4—Alzheimer's disease	2.04e-05	0.000513	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	1.92e-05	0.000482	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TP53—Alzheimer's disease	1.85e-05	0.000465	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	1.82e-05	0.000457	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.74e-05	0.000436	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IL6—Alzheimer's disease	1.7e-05	0.000426	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.66e-05	0.000418	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.6e-05	0.000402	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—AKT1—Alzheimer's disease	1.57e-05	0.000393	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ND1—Alzheimer's disease	1.55e-05	0.000388	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—TPI1—Alzheimer's disease	9.97e-06	0.00025	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CHAT—Alzheimer's disease	9.97e-06	0.00025	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—MAOB—Alzheimer's disease	9.56e-06	0.00024	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	9.2e-06	0.000231	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—A2M—Alzheimer's disease	8.89e-06	0.000223	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ACHE—Alzheimer's disease	7.73e-06	0.000194	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	7.64e-06	0.000192	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ENO1—Alzheimer's disease	7.24e-06	0.000182	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	7.24e-06	0.000182	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	7.1e-06	0.000178	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—BCHE—Alzheimer's disease	6.73e-06	0.000169	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	6.35e-06	0.00016	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	6.16e-06	0.000155	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	5.31e-06	0.000133	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	5.28e-06	0.000133	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—LPL—Alzheimer's disease	4.83e-06	0.000121	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	4.35e-06	0.000109	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CALM1—Alzheimer's disease	4.07e-06	0.000102	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—APOE—Alzheimer's disease	4.05e-06	0.000102	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CAV1—Alzheimer's disease	4.01e-06	0.000101	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PPARG—Alzheimer's disease	3.53e-06	8.86e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—INS—Alzheimer's disease	3.46e-06	8.69e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—NOS3—Alzheimer's disease	3.04e-06	7.62e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	2.78e-06	6.97e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.4e-06	3.5e-05	CbGpPWpGaD
